243 related articles for article (PubMed ID: 3096792)
1. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
[TBL] [Abstract][Full Text] [Related]
2. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
Burger CW; Hompes PG; Korsen TJ; Schoemaker J
Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
[TBL] [Abstract][Full Text] [Related]
3. Induction of ovulation by prolonged pulsatile administration of luteinizing hormone releasing hormone (LRH) in patients with clomiphene resistant polycystic ovary-like disease.
Burger CW; van Kessel H; Schoemaker J
Acta Endocrinol (Copenh); 1983 Nov; 104(3):357-64. PubMed ID: 6415997
[TBL] [Abstract][Full Text] [Related]
4. Pituitary response during pulsatile luteinizing hormone-releasing hormone ovulation--induction in patients with clomiphene citrate-resistant polycystic ovary-like disease.
Burger CW; Korsen TJ; Schoemaker J
Gynecol Endocrinol; 1988 Mar; 2(1):19-33. PubMed ID: 3140589
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
6. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
[TBL] [Abstract][Full Text] [Related]
7. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS
Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453
[TBL] [Abstract][Full Text] [Related]
9. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
Saffan DS; Seibel MM
J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
[TBL] [Abstract][Full Text] [Related]
10. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
[TBL] [Abstract][Full Text] [Related]
12. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
[TBL] [Abstract][Full Text] [Related]
13. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
14. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy after prolonged pulsatile administration of luteinizing hormone-releasing hormone in a patient with clomiphene-resistant secondary amenorrhea.
Schoemaker J; Simons AH; van Osnabrugge GJ; Lugtenburg C; van Kessel H
J Clin Endocrinol Metab; 1981 May; 52(5):882-5. PubMed ID: 6785291
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
[TBL] [Abstract][Full Text] [Related]
17. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
Saffan D; Seibel MM
Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome.
Eshel A; Abdulwahid NA; Armar NA; Adams JM; Jacobs HS
Fertil Steril; 1988 Jun; 49(6):956-60. PubMed ID: 3286291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
